Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bionomics Ltd (BNOEF)

Bionomics Ltd (BNOEF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,452
  • Shares Outstanding, K 1,309,557
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 1.86
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BNOEF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0027 +25.93%
on 08/30/23
0.0099 -65.66%
on 08/22/23
-0.0065 (-65.66%)
since 08/18/23
3-Month
0.0013 +161.54%
on 08/14/23
0.0260 -86.92%
on 06/23/23
-0.0101 (-74.81%)
since 06/16/23
52-Week
0.0013 +161.54%
on 08/14/23
0.0550 -93.82%
on 11/16/22
-0.0316 (-90.29%)
since 09/16/22

Most Recent Stories

More News
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment TORONTO, ON / ACCESSWIRE / February 11, 2021 / Novamind Inc. (CSE:NM) ("Novamind"), a leading mental health company...

BNO.AX : 0.010 (unch)
NM.CN : 0.295 (unch)
BNO : 31.65 (+2.00%)
BNOEF : 0.0034 (-43.33%)
Recapitalisation Led by Sophisticated Life Sciences Investor - Apeiron Investment Group Ltd

Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical stage biopharmaceutical company, today announced that it has entered into a Subscription Agreement, with Apeiron Investment...

BNO.AX : 0.010 (unch)
BNOEF : 0.0034 (-43.33%)
Bionomics and MSD Scientists Publish Preclinical Findings for BNC375 in Peer-Reviewed Journal

Bionomics Limited (ASX: BNO, OTCQB:BNOEF), a global, clinical stage biopharmaceutical company, today announced that a paper describing the pharmacology of BNC375, a novel positive allosteric modulator...

BNO.AX : 0.010 (unch)
BNOEF : 0.0034 (-43.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0034
2nd Resistance Point 0.0034
1st Resistance Point 0.0034
Last Price 0.0034
1st Support Level 0.0034
2nd Support Level 0.0034
3rd Support Level 0.0034

See More

52-Week High 0.0550
Fibonacci 61.8% 0.0345
Fibonacci 50% 0.0281
Fibonacci 38.2% 0.0218
Last Price 0.0034
52-Week Low 0.0013

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar